ARCOSA INC (ACA) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ACA - US0396531008 - Common Stock
108.69 USD
+1.64 (+1.53%)
Taking everything into account, ACA scores 5 out of 10 in our fundamental rating. ACA was compared to 55 industry peers in the Construction & Engineering industry. Both the profitability and the financial health of ACA get a neutral evaluation. Nothing too spectacular is happening here. ACA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ACA was profitable.
In the past year ACA had a positive cash flow from operations.
In the past 5 years ACA has always been profitable.
In the past 5 years ACA always reported a positive cash flow from operatings.
1.2 Ratios
ACA has a Return On Assets of 2.94%. This is comparable to the rest of the industry: ACA outperforms 47.27% of its industry peers.
The Return On Equity of ACA (5.75%) is worse than 60.00% of its industry peers.
ACA's Return On Invested Capital of 4.99% is in line compared to the rest of the industry. ACA outperforms 43.64% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACA is significantly below the industry average of 17.90%.
The last Return On Invested Capital (4.99%) for ACA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROIC | 4.99% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
Looking at the Profit Margin, with a value of 5.25%, ACA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
ACA's Profit Margin has declined in the last couple of years.
ACA's Operating Margin of 10.27% is fine compared to the rest of the industry. ACA outperforms 72.73% of its industry peers.
In the last couple of years the Operating Margin of ACA has declined.
Looking at the Gross Margin, with a value of 21.61%, ACA is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
ACA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACA is destroying value.
Compared to 1 year ago, ACA has more shares outstanding
Compared to 5 years ago, ACA has more shares outstanding
ACA has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.42 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ACA (2.42) is comparable to the rest of the industry.
The Debt to FCF ratio of ACA is 5.03, which is a neutral value as it means it would take ACA, 5.03 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.03, ACA is doing good in the industry, outperforming 61.82% of the companies in the same industry.
A Debt/Equity ratio of 0.61 indicates that ACA is somewhat dependend on debt financing.
ACA has a Debt to Equity ratio of 0.61. This is comparable to the rest of the industry: ACA outperforms 58.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 2.42 |
ROIC/WACC0.51
WACC9.74%
2.3 Liquidity
ACA has a Current Ratio of 2.02. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
ACA has a Current ratio of 2.02. This is amongst the best in the industry. ACA outperforms 87.27% of its industry peers.
ACA has a Quick Ratio of 1.30. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
ACA has a Quick ratio (1.30) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
ACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.03%, which is quite good.
Measured over the past 5 years, ACA shows a small growth in Earnings Per Share. The EPS has been growing by 5.16% on average per year.
The Revenue has grown by 13.96% in the past year. This is quite good.
ACA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.15% yearly.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
ACA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.53% yearly.
Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 7.41% on average per year.
EPS Next Y41.21%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue Next Year10.81%
Revenue Next 2Y8.38%
Revenue Next 3Y7.41%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ACA is valuated quite expensively with a Price/Earnings ratio of 28.75.
Compared to the rest of the industry, the Price/Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 63.64% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. ACA is around the same levels.
With a Price/Forward Earnings ratio of 22.30, ACA is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 76.36% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ACA to the average of the S&P500 Index (23.56), we can say ACA is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.75 | ||
| Fwd PE | 22.3 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACA is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
ACA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACA is cheaper than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.95 | ||
| EV/EBITDA | 12.79 |
4.3 Compensation for Growth
ACA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ACA's earnings are expected to grow with 22.53% in the coming years.
PEG (NY)0.7
PEG (5Y)5.57
EPS Next 2Y27.26%
EPS Next 3Y22.53%
5. Dividend
5.1 Amount
With a yearly dividend of 0.19%, ACA is not a good candidate for dividend investing.
ACA's Dividend Yield is a higher than the industry average which is at 1.66.
With a Dividend Yield of 0.19, ACA pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
5.2 History
The dividend of ACA decreases each year by -0.48%.
ACA has been paying a dividend for over 5 years, so it has already some track record.
As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
NYSE:ACA (12/9/2025, 3:47:37 PM)
108.69
+1.64 (+1.53%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners94.79%
Inst Owner Change-4.44%
Ins Owners1.8%
Ins Owner Change-2%
Market Cap5.33B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target122.23 (12.46%)
Short Float %2.25%
Short Ratio4.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)3.3%
PT rev (3m)3.3%
EPS NQ rev (1m)2.28%
EPS NQ rev (3m)3.23%
EPS NY rev (1m)3.78%
EPS NY rev (3m)5.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.75 | ||
| Fwd PE | 22.3 | ||
| P/S | 1.88 | ||
| P/FCF | 16.95 | ||
| P/OCF | 11.36 | ||
| P/B | 2.06 | ||
| P/tB | 5.8 | ||
| EV/EBITDA | 12.79 |
EPS(TTM)3.78
EY3.48%
EPS(NY)4.87
Fwd EY4.49%
FCF(TTM)6.41
FCFY5.9%
OCF(TTM)9.57
OCFY8.8%
SpS57.76
BVpS52.7
TBVpS18.72
PEG (NY)0.7
PEG (5Y)5.57
Graham Number66.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROCE | 6.5% | ||
| ROIC | 4.99% | ||
| ROICexc | 5.24% | ||
| ROICexgc | 8.62% | ||
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% | ||
| FCFM | 11.11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 3.04 | ||
| Cap/Depr | 68.36% | ||
| Cap/Sales | 5.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.74% | ||
| Profit Quality | 211.71% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 2.42 |
F-Score5
WACC9.74%
ROIC/WACC0.51
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y41.21%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.81%
Revenue Next 2Y8.38%
Revenue Next 3Y7.41%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.94%
EBIT Next 3Y39.06%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
What is the valuation status for ACA stock?
ChartMill assigns a valuation rating of 5 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
Can you provide the profitability details for ARCOSA INC?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARCOSA INC (ACA) stock?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 28.75 and the Price/Book (PB) ratio is 2.06.
What is the expected EPS growth for ARCOSA INC (ACA) stock?
The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 41.21% in the next year.